XERS Market Cap & Key Metrics
Xeris Biopharma Holdings, Inc.
$16.65
+$0.13(+0.79%)
63
Overall
40
Value
83
Tech
68
Quality
Market Cap
$3.04B
Volume
2.27M
52W Range
$5.25 - $15.21
Target Price
$14.00
XERS market cap is $3.04B. This page lists Xeris Biopharma Holdings, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
XERS Key Metrics
- Market cap
- $3.04B
- P/E ratio (current-year EPS estimate)
- 237.86
- EPS estimate, current year
- $0.07
- EPS growth, 3-year
- +0.00%
- Value score
- 40
- Quality score
- 68
- Technical score
- 83
| Fiscal year | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | $33.20M | $110.25M | $49.59M |
| EBITDA | -$9.21M | -$67.75M | -$116.71M |
| EPS | $-0.12 | $-0.70 | $-1.55 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | XERS | $16.65 | +0.8% | 2.27M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Xeris Biopharma Holdings, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW